Carbapenem de-escalation therapy in a resource-limited setting

Infection Control and Hospital Epidemiology

Volumn 34, Issue 12, 2013, Pages 1310-1313

  Apisarnthanarak, Anucha ^a   Bhooanusas, Nuntanij ^a   Yaprasert, Apiwat ^b   Mundy, Linda M ^b  

^a THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^b Padreaw Medical Equipment Shop ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DE ESCALATION; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PATHOGENESIS; PHARMACOLOGICAL PARAMETERS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; FEMALE; GENTIAN VIOLET; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PHENAZINES; REFERRAL AND CONSULTATION; SHOCK, SEPTIC; THAILAND; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84887579199     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/673976     Document Type: Article

References (12)

1. Apisarnthanarak A, Hsu LY, Khawcharoenporn T, Mundy LM. Carbapenem-resistant gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings? Expert Rev Anti Infect Ther 2013;11:147-157.
2. Rello J. Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia. Eur Respir Rev 2007;16:33-39.
3. Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Crit Care 2001;5:189-195.
4. Apisarnthanarak A, Mundy LM. Role of combination antibiogram in empirical treatment of infection due to multidrugresistant Acinetobacter baumannii. Infect Control Hosp Epidemiol 2008;29:678-679.
5. Apisarnthanarak A, Kiratisin P, Mundy LM. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infect Control Hosp Epidemiol 2008;29:1026-1034.
6. Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008;46:1121-1122.
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140.
8. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
9. Masterton RG. Antibiotic de-escalation. Crit Care Clin 2011;27: 149-162.
10. Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 2007;33:1533-1540.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. Deescalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care 2010;25:641-646.
12. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44: 159-177.